Donepezil and memantine for moderate-to-severe Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

http://www.wikidata.org/entity/Q34636487

about

Behavioral and psychological symptoms of dementia Simulated presence therapy for dementia Potential drug-drug interactions in Alzheimer patients with behavioral symptoms The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people Recent advances in the application of metabolomics to Alzheimer's Disease 2012 -- That was the year that was Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer's disease Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer's disease: a review of clinical trials Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors Non-pharmacological cognitive intervention for aging and dementia: Current perspectives Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease Alzheimer's disease: Targeting the Cholinergic System A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease Dementia.Dementia: timely diagnosis and early intervention Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study The timing of drug funding announcements relative to elections: a case study involving dementia medications Long-term oral administration of hop flower extracts mitigates Alzheimer phenotypes in mice Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series.Drug repurposing from the perspective of pharmaceutical companies.Simulated presence therapy for dementia.Can zebrafish be used as animal model to study Alzheimer's disease?Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.Alzheimer's disease drug-development pipeline: few candidates, frequent failures Effects on caregiver burden of a donepezil hydrochloride dosage increase to 10 mg/day in patients with Alzheimer's disease Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.Clinical significance in dementia research: a review of the literature.Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance.Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias Current and future treatments for Alzheimer's disease The impact of Medicare prescription drug coverage on the use of antidementia drugs.Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.Preventing loss of independence through exercise (PLIÉ): a pilot clinical trial in older adults with dementia.The contribution of diseases to the male-female disability-survival paradox in the very old: results from the Newcastle 85+ study.Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer's drug candidates Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysis

P2860

Q21129432-E7E9FEB0-0DA7-4F2A-B356-265170D506F3 Q24187490-6A509DAC-2875-43AA-8747-F85A365E21C8 Q26782490-DAA8A572-0514-4CC6-B756-F82869783909 Q26799352-9E185F10-0C30-48BF-AD37-DB4518EDEE5F Q26828606-48CF1AF5-2CF1-437D-BE05-4EAB8B055957 Q26829471-27DEAA75-98AA-4234-8A53-1339A7D787B3 Q26829899-09F08B17-9530-4589-82E2-578C2F7EA2ED Q26851862-2886A09D-244A-4232-BCB7-66CBC0FF1481 Q26861399-28998A3E-A015-485B-9B41-7B8E942A5A9E Q26997299-10661ABE-EDE7-4AA0-9944-752F0C03AA8D Q27023484-3DD3D853-1A6F-4FD9-AA33-8A0A7060FAFE Q27025207-FE6B9363-76DC-48F2-B109-01FCD6D3B352 Q28070135-DC25BBED-77C4-4AA5-A7C6-D70204525D96 Q28076715-280D47FB-2BC3-4D26-9954-EA6CEC0C33A6 Q28081075-12598071-C593-4F6F-A2DD-E2C39F7B01D7 Q28082444-1621D899-B525-4931-8EE2-55C40B601089 Q28484216-CA9933CF-35E5-42BD-9D8E-76DE0D2E5329 Q28486951-22AA60A1-484C-4905-8E5D-92FC7CC4AF7D Q28539305-904F445F-D1E8-4BAD-8E89-4107BF8C5233 Q30400013-F105EA5B-7DBD-477B-849E-9AE2B40A2807 Q30400634-971CC4DD-2F4C-4F5C-BE2D-5BA3C013DEA7 Q30401151-25E9996F-4803-40E1-86D2-B0A8C01CEE74 Q30458465-C7657444-12B2-4527-BC91-D4FC466072C1 Q31155412-23523FD4-AA05-4BB8-99E0-E812AF3BC974 Q33165801-B13B8C03-C9F7-478E-97C8-D7B6BF57B255 Q33454879-E4907076-9558-41AE-97D6-038D4C0E06FB Q33556068-7346955B-9B59-4992-9B58-29AEDDCDACBF Q33892815-CA5FF5D1-E5E4-4A73-9C25-F52569502278 Q34230445-AE7A269E-05C8-402F-941B-ADDB414D0054 Q34327769-2F769ADD-D1F4-42C6-BF3B-61B61711D30B Q34404220-F5A86739-37C0-45DB-84CE-60D5B6BE8BA7 Q34463351-762CCDD0-E9FA-45E5-99CA-B08422BAAAF0 Q34528182-D2A6C9A9-C635-4075-9BF5-86D091A236D0 Q34646921-662D1AE0-6771-4CBC-AC9B-39BD062D3985 Q34690333-77960E69-AE4C-4006-A427-6F551BBE4C1D Q35006354-E8953B03-C323-49E5-AE1B-2FB768BA69E3 Q35074465-6CEAA095-BCA6-43D3-A481-3D7F134AA4FF Q35091510-4202DE59-7E48-4257-8699-B174803C2814 Q35167977-A30E3B06-0A1A-4F42-8FD9-98D808B461C1 Q35224319-19936324-8EAE-455D-B5C6-D0B3D2893F61

P2860

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

http://www.wikidata.org/entity/Q34636487

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@ast

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@en

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@nl

type

label

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@ast

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@en

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@nl

prefLabel

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@ast

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@en

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

@nl

P1433

Q34636487-A9718BA7-C627-4C29-9A2F-73D223785ABE

P1476

Q34636487-EAC22ECE-7023-4BA8-9DF0-B494E5EB0C13

P2093

Q34636487-022CBA6C-F746-4071-A5A7-BF79DCAAE2A8

Q34636487-0A997F0F-E0CA-4440-9459-D95883D54295

Q34636487-2D746DFA-5870-4C9B-B283-37DA0806A285

Q34636487-42707CF7-4304-4DEF-A621-4E36C46449A3

Q34636487-601B4A9F-6D42-46CC-85B0-12A4325A7082

Q34636487-6C689BE4-32D3-45E6-B457-A6FB4AFAD527

Q34636487-74ABABBF-4294-4FE8-A4BF-8256B3CF2E4C

Q34636487-74B019D1-CC22-4309-8A27-ECF81470DFFF

Q34636487-77958EC4-DFCF-4DFB-8F36-3950FE24D66B

Q34636487-806FBB25-9F75-4CB9-BAAD-F52E25D9AD5A

P304

Q34636487-47117181-4FE8-4E49-BE7F-B125CCB56B07

P31

Q34636487-73318EB9-D2E7-46B0-B098-95DEAF23498C

P356

Q34636487-1F27C247-9047-4C5F-A912-664AF45AAA5A

P407

Q34636487-EC61E125-72EC-446D-85EE-66A6507F066B

P433

Q34636487-0E43A7A0-02DD-4EF0-AEBC-3F7EC92A414B

P478

Q34636487-2B90D08D-9F59-4B58-929F-A866333E11E0

P50

Q34636487-30D7C2D3-F3C9-4842-98C7-826F57546DD1

Q34636487-3BBAE969-0C0B-4B3E-8988-A591D5D9CD2D

Q34636487-3EFDF6DA-7FDE-4E37-93F8-E0D8C9308D67

Q34636487-5CB435FC-BC80-499D-8A18-1FAE031F3897

Q34636487-84C2065D-B7E5-4BFA-BA8F-052238065663

Q34636487-8FDE5410-A11A-4357-BEEE-BC529D82F40D

Q34636487-A7C50CA1-BC65-4451-84D6-83A19414EC02

Q34636487-C784E48E-DB70-4DA0-A8E8-680B6A6B112C

Q34636487-CB356026-BC0A-4E29-B696-F273EFD5B690

Q34636487-DC647765-A209-4B48-9276-E49DE135F7D2

P577

Q34636487-7C5F543D-2793-4839-919F-08E25B816FAB

P698

Q34636487-4AA0A51A-40AF-47BA-B3AC-57E98C64A3AC

P921

Q34636487-A2AB3487-4CD9-4AC8-BFC3-0B2464CEB7AD

P356

P1433

The New England Journal of Medicine

P1476

Donepezil and memantine for moderate-to-severe Alzheimer's disease

@en

P2093

Ajay Macharouthu

http://www.w3.org/2001/XMLSchema#string

Alan Hughes

http://www.w3.org/2001/XMLSchema#string

Ashley Baldwin

http://www.w3.org/2001/XMLSchema#string

Bart Sheehan

http://www.w3.org/2001/XMLSchema#string

Caroline Onions

http://www.w3.org/2001/XMLSchema#string

Cornelius Katona

http://www.w3.org/2001/XMLSchema#string

Craig Ritchie

http://www.w3.org/2001/XMLSchema#string

David Findlay

http://www.w3.org/2001/XMLSchema#string

Edmund Juszczak

http://www.w3.org/2001/XMLSchema#string

James Lindesay

http://www.w3.org/2001/XMLSchema#string

P304

893-903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1106668

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

366

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Phillips

Richard G Brown

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22397651

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease